Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
905.38
-3.66 (-0.40%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
85
86
Next >
LLY Stock Jumps After FDA Approves Eli Lilly’s Tirzepatide Drug For Weight Loss
November 08, 2023
Eli Lilly And Co’s stock saw a notable surge, trading at $610.50, up 1.69% (+$10.14) today, following the Food and Drug Administration’s approval of their blockbuster drug tirzepatide for weight...
Via
Talk Markets
Exposures
Product Safety
Weight Loss Drug Competition - FDA Approves Expanded Use Of Eli Lilly's Blockbuster Tirzepatide For Weight Loss, Undercutting Novo Nordisk's Price
November 08, 2023
The FDA has approved
Via
Benzinga
Exposures
Product Safety
Eli Lilly Wins FDA Approval For Highly Anticipated Weight-Loss Drug
November 08, 2023
The drug will sell under the brand name Zepbound.
Via
Investor's Business Daily
Exposures
Product Safety
10 Health Care Stocks Whale Activity In Today's Session
November 08, 2023
Via
Benzinga
Eli Lilly Slashed Its Earnings Guidance and Its Stock Went Up 5% Anyway. What's Next?
November 08, 2023
Aggressive investments in growth have left the pharma giant with smaller profits this year.
Via
The Motley Fool
Eli Lilly Unusual Options Activity
November 07, 2023
Via
Benzinga
What Happened With Eli Lilly and Company Stock Today?
November 06, 2023
Eli Lilly and Company (NYSE: LLY) shares traded higher on Monday.
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
November 06, 2023
Via
Benzinga
Humana, Eli Lilly And A Major Mining Stock On CNBC's 'Final Trades'
November 07, 2023
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc. (NYSE: FCX), adding that she likes the stock
Via
Benzinga
3 Ultra-Safe Dividend Stocks to Buy Hand Over Fist in November
November 07, 2023
These three blue chips ought to be reliable, long-term income generators.
Via
The Motley Fool
Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday
November 06, 2023
Eli Lilly jumped, while energy plays were big winners and losers.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners
November 06, 2023
Roku vaulted 50% to become Ark Innovation's top holding.
Via
Investor's Business Daily
Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion
November 04, 2023
Jiangsu Hengrui Pharma out-licensed global rights for its next-gen PARP1 inhibitor to Germany’s Merck KGaA for a $170 million upfront payment and up to $1.5 billion in milestones. Merck will have...
Via
Talk Markets
Check Out What Whales Are Doing With LLY
November 03, 2023
Via
Benzinga
Eli Lilly Just Added Another Potential Billion-Dollar Product: Is It a Buy?
November 03, 2023
The answer is relatively clear.
Via
The Motley Fool
Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
November 03, 2023
Markets bounced back decisively this week, shrugging off prior volatile months marked by heightened geopolitical tensions. The resurgence of risk sentiment ignited a relief rally in both equities and...
Via
Benzinga
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
The Importance of Brand Power: 3 Stocks to Consider
November 03, 2023
Count on these companies, whose reputations and brands are growing, leading their popular brand stocks to new heights.
Via
InvestorPlace
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
Why Eli Lilly Stock Is Jumping Today
November 02, 2023
Investors liked the drugmaker's Q3 update.
Via
The Motley Fool
Eli Lilly Smashes Third-Quarter Forecasts As Diabetes Blockbuster Grows 652%
November 02, 2023
Mounjaro helped drive a third-quarter beat, growing sevenfold.
Via
Investor's Business Daily
Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?
November 03, 2023
Lilly's Mounjaro is gaining ground on Novo Nordisk's Ozempic.
Via
The Motley Fool
Eli Lilly (LLY) Q3 2023 Earnings Call Transcript
November 02, 2023
LLY earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Treasuries, Stocks Extend Gains Following Fed Meeting As Apple, Jobs Report Loom
November 02, 2023
(Thursday market open) The World Series is over, but Wall Street remains in the thick of this week’s triple play of a Fed meeting, Apple (NASDAQ: AAPL) earnings and Friday’s October jobs report. So...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Some Surprise Names Led The S&P 500 In October
November 02, 2023
The best and worst stock performers in the S&P 500 for October include some surprising names.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Weight Loss Drugs Drove Eli Lilly's Massive Profit - But They Still Cut Their Annual Profit Guidance, Here's Why
November 02, 2023
Eli Lilly And Co (NYSE: LLY) has reported Q3 sales of $9.49 billion, up 37% Y/Y, beating the consensus of $8.95 billion, dr
Via
Benzinga
Weight Watchers Q3 Earnings Preview: Will Ozempic Weigh Down WW Stock?
November 02, 2023
Weight Watchers stock, trading as WW, is already down 30% YTD. Here's what analysts will be watching in the Q3 earnings report.
Via
Benzinga
US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple
November 02, 2023
After the Federal Reserve‘s decision, the stock market rally is poised to gain momentum on Thursday, with stock futures indicating an uptick.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
7 A-Rated Tech Stocks to Buy for November
November 02, 2023
By investing in tech stocks, investors can capitalize on groundbreaking technological advancements and be a part of the future.
Via
InvestorPlace
Fear Continues To Grip Markets After Fed's Rate Decision
November 02, 2023
The CNN Money Fear and Greed index remained in the "Fear" zone on Wednesday. U.S. stocks closed higher on Wednesday after the Federal Reserve maintained interest rates for a second straight time. Bond...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
November 01, 2023
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic.
Via
Talk Markets
Exposures
COVID-19
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
85
86
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.